Elias Zerhouni, the head of research and development at Sanofi and the former director of the National Institutes of Health, says a concerted effort was needed to make sure that existing efforts at cutting clinical trial costs do not fail.

FORBES: Ten Pharmas Aim To Cut Red Tape To Speed Drug Development

The FTTA allowed government laboratories like the National Institutes of Health (NIH) to enter into Cooperative Research and Development Agreements (CRADAs) with the pharmaceutical industry.

FORBES: Sen. Wyden's Proposal Will Kill NIH-Pharma Collaboration